Glenmark settles with Triax/Astellas for eczema product
This article was originally published in Scrip
Executive Summary
Glenmark Pharmaceuticals expects to launch its generic version of Astellas Pharma/Triax Pharmaceuticals' eczema treatment, Locoid Lipocream (0.1% hydrocortisone butyrate cream), in the US towards the end of 2013, following a settlement pact with the originators.